International Society of Ocular Oncology
ISOO is the dedicated international professional society for ocular oncology, connecting 600+ clinicians, researchers, and scientists across 68 countries through biennial congresses, year-round webinars, the Ocular Oncology and Pathology journal, travel grants, and collaborative research programs.
- Company typePrivate
- Founded2004
- HeadquartersPhiladelphia, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What International Society of Ocular Oncology does
The International Society of Ocular Oncology (ISOO) is a non-profit professional medical society incorporated in Pennsylvania, USA in 2004 and headquartered in Fremont, Wisconsin, dedicated exclusively to ocular oncology, the diagnosis and treatment of tumors of the eyelids, conjunctiva, intraocular structures, and orbit. ISOO connects 600+ clinicians, researchers, and scientists across 68 countries and six continents through a portfolio of membership-based programs anchored by a biennial in-person congress (Athens 2028, Singapore 2030, Miami 2032), an alternating-year virtual congress that drew more than 1,500 participants from 132 countries in 2025, quarterly webinar series, the Ocular Oncology and Pathology Grand Rounds with Cleveland Clinic CME credit, and the YOOG and WOO committees for early-career and women specialists. The society runs six membership categories (Ordinary, Member-in-Training, Collaborating, Allied, Emeritus, Honorary) at a uniform $150 annual dues rate, awards 100+ named travel grants annually to members in training and colleagues in low- and middle-income countries, and operates a Global Twinning Program that pairs ocular-oncology centers across income settings. Supporting offerings include a Collaborative Research Program, the ISOO Collaborations Framework for structured event partnerships, and free member access to the Ocular Oncology and Pathology journal published by Karger. Revenue is generated from membership dues, congress and virtual congress registration fees, and program-related fees; the society has no parent company, subsidiaries, or disclosed investors and is governed by an elected Board of Directors (2026-2028 term).
International Society of Ocular Oncology firmographics
Firmographics- Name
- International Society of Ocular Oncology
- Legal name
- International Society of Ocular Oncology
- Website
- https://isoo.org
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ISOO is the dedicated international professional society for ocular oncology, connecting 600+ clinicians, researchers, and scientists across 68 countries through biennial congresses, year-round webinars, the Ocular Oncology and Pathology journal, travel grants, and collaborative research programs.
- Ownership category
- akta.pro rank
Where International Society of Ocular Oncology is headquartered
LocationHeadquarters
- HQ city
- Philadelphia
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
International Society of Ocular Oncology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Membership Dues: Annual membership dues at a flat rate of $150 USD across all membership categories, with Emeritus members exempt from dues. Membership grants access to congresses, journals, webinars, and member-only resources.
- Conference Registration Fees: Registration fees for biennial in-person congresses and virtual congress events. Non-members pay full registration while members receive free or discounted access.
- Journal Access: Free access to Ocular Oncology and Pathology journal included with membership. The journal is published by Karger.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Ordinary Members - Voting members including physicians and scientists focused on ocular oncology |
| Subscription | Annual | Member-in-Training - For trainees in medical, scientific, or allied health programs related to ocular oncology |
| Subscription | Annual | Collaborating Members - Professionals in healthcare or research intersecting with ocular oncology but not primarily focused |
| Subscription | Annual | Allied Members - Professionals in biopharma, medical devices, NGOs, or support organizations related to ocular oncology |
| Subscription | Annual | Emeritus Members - Retired Ordinary Members who attended at least four Regular ISOO Meetings |
| Subscription | Annual | Honorary Members - Exceptional contributors to ocular oncology or the Society, by nomination only |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
International Society of Ocular Oncology product offering
Product offeringCore offering
ISOO is a non-profit professional medical society that connects 600+ clinicians, researchers, and scientists in ocular oncology across 68 countries. Its core offerings are membership-based programs (six categories at $150 USD/year), biennial in-person congresses, an alternating-year virtual congress, quarterly webinar series, named travel grants, collaborative research projects, the Global Twinning Program, and free access to the Ocular Oncology and Pathology journal published by Karger.
Product overview
The International Society of Ocular Oncology (ISOO) is a professional society rather than a software product company, offering a portfolio of membership-based programs and services. The core offerings include the ISOO Biennial Congress and ISOO Virtual Congress (alternating in-person and virtual formats), the ISOO Webinar Series, YOOG Webinar Series, and Ocular Oncology and Pathology Grand Rounds for continuing education. Supporting programs include Travel Grants (awarded to 100+ members annually), Collaborative Research initiatives, the Global Twinning Program, and the ISOO Collaborations Framework. ISOO membership ($150/year across six categories) provides access to all programs plus the Ocular Oncology and Pathology journal, YOO/WOO networks, and member directories.
Differentiator
Problem solved
Functional benefit
Brands
- YOO (Young Ocular Oncologists): ISOO's young specialists initiative coordinating webinars, mentoring opportunities, and events for trainees and early-career clinicians in ocular oncology.
- WOO (Women in Ocular Oncology)
Products and services
- ISOO Membership Professional membership program with six categories priced at $150 USD per year, providing access to congresses, webinars, the Ocular Oncology and Pathology journal, travel grants, and committee participation. Targeted at physicians, scientists, trainees, allied industry professionals, and retirees in ocular oncology.
- ISOO Biennial Congress Flagship in-person congress held every two years in rotating cities worldwide, featuring scientific sessions, named lectures, awards, and networking for ocular oncology professionals. Members receive $300+ savings on registration.
- ISOO Virtual Congress Full virtual congress held in alternating years to the biennial in-person congress, providing online access to scientific programming, webinars, and networking. Free for members; ISOO Virtual 2025 attracted 1,500+ participants from 132 countries.
- ISOO Webinar Series Quarterly webinar series anchored to global awareness moments, covering retinoblastoma, uveal melanoma, ocular surface tumors, and other ocular oncology topics. Free for members.
- YOOG Webinar Series Young Ocular Oncology Group webinar series featuring quarterly educational sessions with expert speakers covering challenging cases, surgical techniques, and multidisciplinary collaboration for trainees and early-career specialists.
- Ocular Oncology and Pathology Grand Rounds Monthly educational series where residents and fellows present ocular oncology and pathology cases with expert moderator commentary. Offers CME credit through Cleveland Clinic.
- Travel Grants Named travel grants awarded annually to more than 100 members, prioritizing members in training and colleagues in low- and middle-income countries to attend the ISOO Congress.
- Collaborative Research Program Member-led multicenter studies and collaborative projects spanning research, publications, and educational support. Includes active studies on choroidal melanocytic lesions, vitreoretinal lymphoma, retinoblastoma treatments, and transvitreal biopsy training.
- Global Twinning Program Pairs ocular-oncology centers across high- and low-income countries to share clinical expertise, provide research advice, and facilitate training opportunities for improved patient outcomes worldwide.
- ISOO Collaborations Framework Three-tier framework enabling members and organizations to request formal collaboration on meetings, symposia, and educational programs (ISOO Partner Event, In Collaboration with ISOO, ISOO Symposium or Session).
- Ocular Oncology and Pathology Journal Peer-reviewed journal published by Karger providing full access to members, with free publication for member submissions.
- Ocular Oncology Societies Directory Global directory mapping ocular-oncology societies, consortia, working groups, networks, and clubs to help trainees, researchers, and clinicians access local resources and collaborative projects.
- YOO Directory Directory listing clinicians and researchers interested in Young Ocular Oncologists initiatives to facilitate networking, collaboration, and information sharing among early-career specialists.
- Women in Ocular Oncology (WOO) Initiative supporting and promoting mentorship and growth opportunities for women in ocular oncology through academic collaboration, networking, and fellowship among members.
- Young Ocular Oncologists (YOO) Committee and initiatives supporting trainees and early-career ocular oncologists through webinars, mentoring, networking, and events including the traditional YOO lunch at biennial congresses.
- Eye Tumors Resource Educational resource providing information on eyelid, conjunctiva, intraocular, retina, and orbit tumors including clinical features, pathology, and treatment options.
- Ocular Oncology Books Resource collection of ocular oncology textbooks and reference materials available to members.
Quantifiable outcome
- ISOO Virtual 2025 reached more than 1,500 participants from 132 countries
- +2 more outcomes
Companies that use International Society of Ocular Oncology
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
International Society of Ocular Oncology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
International Society of Ocular Oncology partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and support.
- International Society of Pediatric Oncology (SIOP)coreStrategic alliance between ISOO and SIOP uniting world's leading ocular and pediatric oncology experts to accelerate progress in retinoblastoma diagnosis, treatment, and long-term care. Includes joint education and events (co-branded webinars, conference tracks, virtual roundtables), collaborative research and guidelines development, and WHO advocacy through SIOP's non-state actor status. ISOO's President and President-Elect serve as official delegates within SIOP's retinoblastoma initiatives.
- American Association of Ophthalmic Oncologists and Pathologists (AAOOP)corePartnership on Young Specialists initiatives including quarterly webinars (YOOG series), mentorship programs, and professional development opportunities. Jointly coordinated by Dr. Maura Di Nicola (ISOO) and AAOOP leadership. ISOO and AAOOP members receive notifications through respective communication channels.
- XCD SystemssupportEvent-management and membership platform hosting registration forms, virtual conference tools, member directory, and abstract submission for ISOO events.
- Karger PublisherscorePublisher of Ocular Oncology and Pathology journal, providing free access to ISOO members as a membership benefit.
- Google AnalyticssupportAnalytics provider used to understand website visitor navigation and behavior.
Scale indicators8 records
Recent moves9 records
Expansion highlights6 records
International Society of Ocular Oncology competitors and assessment
Company assessmentBroad incumbents
- American Academy of Ophthalmology (AAO): The largest U.S. professional society for ophthalmologists. Broad incumbent that encompasses ocular oncology as a subspecialty track and competes with ISOO for member dues and meeting attention.
- European Society for Medical Oncology (ESMO): Leading European professional society for medical oncology. Broad incumbent whose congress and journal ecosystem overlaps with ocular oncology clinicians treating uveal melanoma and other ocular cancers.
- American Society of Clinical Oncology (ASCO): Largest global oncology professional society covering medical, radiation, and surgical oncology. Broad incumbent that increasingly includes ocular oncology sessions and competes for industry sponsorship that could otherwise flow to ISOO.
- International Council of Ophthalmology (ICO): Global umbrella body for ophthalmology societies and ophthalmologic education. Broad incumbent representing national societies worldwide that ISOO members also engage with.
- European Society of Ophthalmology (SOE): Pan-European ophthalmology professional society covering all subspecialties including ocular oncology. Broad incumbent whose congress programming overlaps with ISOO's biennial meetings.
Regional players
- European Retinoblastoma Group (EURbG): European clinical network coordinating retinoblastoma treatment and research across European centers. Regional player with overlapping retinoblastoma mission but narrower geographic remit than ISOO.
Direct peers
- American Association of Ophthalmic Oncologists and Pathologists (AAOOP): North American professional society for ophthalmic oncology and pathology. Direct peer as it serves the same subspecialty clinicians and is an active ISOO partner on the YOOG webinar series and Young Specialists programs.
- International Society of Paediatric Oncology (SIOP): Global professional society for pediatric oncology. Direct peer as it shares overlapping membership for retinoblastoma care and is the formal strategic alliance partner of ISOO under the 2025 retinoblastoma initiative.
Others
- International Agency for Research on Cancer (IARC/WHO): WHO's specialized cancer research agency. Adjacent ecosystem player rather than direct competitor; ISOO engages with WHO advocacy through SIOP, making IARC a relevant peer for governance and policy interaction.
Emerging players
- Ocular Melanoma Foundation (OMF): Patient advocacy nonprofit focused on ocular melanoma. Emerging player in the same disease area as ISOO but serving patients and families rather than clinicians, with potential partnership or awareness-amplification overlap.
Market position
Strengths1 record
Weaknesses1 record
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
International Society of Ocular Oncology social profiles
Digital presenceInternational Society of Ocular Oncology compliance and trust
Trust signalCompliance1 record
International Society of Ocular Oncology financial estimates
Financial estimateRevenue estimate
Valuation estimate
International Society of Ocular Oncology leadership team
Management profileNumber of profiles
Profiles6 records
International Society of Ocular Oncology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
International Society of Ocular Oncology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about International Society of Ocular Oncology
What does International Society of Ocular Oncology do?
ISOO is a non-profit professional medical society that connects 600+ clinicians, researchers, and scientists in ocular oncology across 68 countries. Its core offerings are membership-based programs (six categories at $150 USD/year), biennial in-person congresses, an alternating-year virtual congress, quarterly webinar series, named travel grants, collaborative research projects, the Global Twinning Program, and free access to the Ocular Oncology and Pathology journal published by Karger.
Is International Society of Ocular Oncology a public or private company?
International Society of Ocular Oncology is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was International Society of Ocular Oncology founded?
International Society of Ocular Oncology was founded in 2004. It employs 1 to 10 people.
Where is International Society of Ocular Oncology based?
International Society of Ocular Oncology is headquartered in Philadelphia, United States, in the North America region.
How does International Society of Ocular Oncology make money?
Three revenue lines are on record. Membership Dues are the primary driver. The others are conference Registration Fees and journal Access.
Who are International Society of Ocular Oncology's main competitors?
Broad incumbents on record are American Academy of Ophthalmology (AAO), European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), International Council of Ophthalmology (ICO) and European Society of Ophthalmology (SOE). European Retinoblastoma Group (EURbG) is listed as a regional player. Direct peers are American Association of Ophthalmic Oncologists and Pathologists (AAOOP) and International Society of Paediatric Oncology (SIOP). International Agency for Research on Cancer (IARC/WHO) is listed as an others. Ocular Melanoma Foundation (OMF) is listed as an emerging player.
Does International Society of Ocular Oncology have an API?
No public API is recorded for International Society of Ocular Oncology.